CD8A and neoplasm: Through the establishment of glycolytic dominance, for example, tumor cells inhibit glycolysis and the function of antitumor immune cells, such as CD8+ T cells, DCs, and NK cells, to form a tumor-immunosuppressive microenvironment, which ultimately promotes tumor progression and leads to tumor immune escape and therapeutic resistance.